Ariad Pharmaceuticals Inc fka ARIA

[bellweather1]

Early results in our phase I clinical trial of DCC-2036 suggest evidence of clinical benefit.

thanks for the link-

Question remains, just how extensive and enduring is that "clinical benefit" likely to be?